Sarah Carmody | Executive Director, Investor Relations and Corporate Communications |
Anna Protopapas | President and Chief Executive Officer |
Tim Lowinger | Chief Science and Technology Officer |
Brian DeSchuytner | Senior Vice President Finance and Product Strategy |
Jonathan Chang | SVB Leerink |
Boris Peaker | Cowen |
Tom Shrader | BTIG |
Mike Ulz | Baird |
Good morning, and welcome to Mersana Therapeutics' Second Quarter 2020 Conference Call. [Operator Instructions] I would now like to turn the call over to Sarah Carmody, Executive Director, Investor Relations and Corporate Communications. Please proceed.
Good morning. Welcome to Mersana's second quarter 2020 conference call.